Leerink Partnrs Cuts Earnings Estimates for The Cigna Group

The Cigna Group (NYSE:CI) – Investment analysts at Leerink Partnrs cut their Q2 2025 earnings per share (EPS) estimates for shares of The Cigna Group in a report issued on Thursday, January 30th. Leerink Partnrs analyst W. Mayo now expects that the health services provider will post earnings of $7.07 per share for the quarter, down from their prior estimate of $7.31. The consensus estimate for The Cigna Group’s current full-year earnings is $29.66 per share. Leerink Partnrs also issued estimates for The Cigna Group’s Q4 2025 earnings at $8.05 EPS, Q1 2026 earnings at $7.27 EPS, Q3 2026 earnings at $8.94 EPS and Q4 2026 earnings at $8.64 EPS.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company earned $6.79 EPS.

A number of other equities analysts have also recently weighed in on CI. Truist Financial dropped their price target on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Piper Sandler reissued an “overweight” rating and issued a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a research note on Monday. StockNews.com cut The Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Cantor Fitzgerald dropped their price target on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Raymond James reaffirmed a “strong-buy” rating and set a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research note on Friday. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $378.00.

The Cigna Group Price Performance

Shares of NYSE CI opened at $292.56 on Monday. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The firm’s 50-day simple moving average is $294.40 and its 200 day simple moving average is $324.18. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The stock has a market cap of $81.38 billion, a P/E ratio of 23.90, a P/E/G ratio of 0.97 and a beta of 0.54.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be paid a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 2.06%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is currently 45.75%.

Hedge Funds Weigh In On The Cigna Group

Large investors have recently made changes to their positions in the company. Ulland Investment Advisors LLC lifted its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after buying an additional 100 shares during the period. Prospera Private Wealth LLC acquired a new position in The Cigna Group in the third quarter valued at about $37,000. Collier Financial acquired a new position in The Cigna Group in the fourth quarter valued at about $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group in the fourth quarter valued at about $34,000. Finally, Harbor Capital Advisors Inc. acquired a new position in The Cigna Group in the third quarter valued at about $45,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.